Patent US5260224A successfully refreshed from Google Patents.
US5260224A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Therapeutic uses of actin-binding compounds
Assignee: The Brigham and Women's Hospital Inc
•
Filing: 1991-10-10
•
Granted: 1993-11-09
•
Expires: 2011-10-10
Abstract
Abstract A method for decreasing the concentration of free actin in the plasma of an animal is described which comprises the administration of native and modified actin-binding proteins, and especially the administration of native and modified actin-binding regions of gelsolin. Diagnostic methods for identifying animals in need of such treatment are also described.
Inventors
- 👤 Thomas P. Stossel
- 👤 Stuart E. Lind
- 👤 Paul A. Janmey
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 03:01
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/68; G01N33/6887; A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/1703; A61K38/1709; A61P; A61P1/00; A61P1/16; A61P11/00; A61P13/00; A61P13/02; A61P13/12; A61P15/00; A61P21/00; A61P43/00; A61P7/00; A61P7/04; C; C07; C07K; C07K14/00; C07K14/435; C07K14/46; C07K14/47; C07K14/4701; C07K14/4716; G01N33/6893
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
102 words
A method for the detection of extracellular actin in the plasma from a living subject, wherein said actin is free from actin-binding proteins and said plasma is a clinical sample from said subject, said method comprising assaying said sample for the level of said free actin by forming exogenous complexes in said sample consisting essentially of said actin and an actin-binding protein, wherein said actin-binding protein is selected from the group consisting of gelsolin, vitamin D-binding protein (DBP), myosins, tropomyosins, profilin, cofilin, depactin, DNase I, vilin, fragmin, severin, capping protein, β-actinin, and acumentin, and detecting the level of said formed exogenous complexes.
Claim 2
Independent Claim
102 words
A method for the detection of extracellular actin in the plasma from a living subject, wherein said actin is free from actin-binding proteins and said plasma is a clinical sample from said subject, said method comprising assaying said sample for the level of said free actin by forming exogenous complexes in said sample consisting essentially of said actin and an actin-binding protein, wherein said actin-binding protein is selected from the group consisting of gelsolin, vitamin D-binding protein (DBP), myosins, tropomyosins, profilin, cofilin, depactin, DNase I, vilin, fragmin, severin, capping protein, β-actinin, and acumentin, and detecting the level of said formed exogenous complexes.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-11-08 | 1997-05-10 | 1997-11-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-11-08 | 2001-05-10 | 2001-11-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-11-08 | 2005-05-10 | 2005-11-09 | $7700.00 | Window Closed / Lapsed |